Anuh Pharma Limited · ANUHPHR
Every Anuh Pharma Limited result whose ten-session window has closed, judged against the last read made before it. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
7results judged
0read right
0read wrong
0flat / no call
7unread
0%beat the market
-6.3%avg vs market, 10d
5.3%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| unread | 7 | 0 | 0 | 0 | — | -6.3% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
7 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 7 Aug Q1FY27 | — | unread | -2.0% | -0.6% | +0.8% | — | no figures |
|
› |
| 20 May Q4FY26 | — | unread | -6.9% | -6.6% | -5.5% | +11% | no figures |
|
› |
| 6 Feb Q3FY26 | — | unread | +5.9% | -7.1% | -7.2% | +1% | no figures |
|
› |
| 7 Nov Q2FY26 | — | unread | -5.4% | -9.8% | -11.6% | -1% | no figures |
|
› |
| 8 Aug Q1FY26 | — | unread | -3.0% | -3.9% | -5.3% | -14% | no figures |
|
› |
| 23 May Q4FY25 | — | unread | +1.9% | +2.9% | +1.9% | +26% | no figures |
|
› |
| 7 Feb Q3FY25 | — | unread | -12.1% | -21.3% | -17.0% | -6% | no figures |
|
› |